ADGRL4 and breast carcinoma: In 2017, Favara et al. reported that ELTD1 is upregulated in breast cancer endothelium that in turn induced lipid metabolism downregulation [48] and later, in 2019, the same group demonstrated that ELTD1 silencing alters the cell metabolic profile in endothelial cells [32].